NOX 1.52% 6.7¢ noxopharm limited

Exquisite Timing, page-11

  1. 355 Posts.
    lightbulb Created with Sketch. 58

    Hi Rbx,

    I'mjust querying these results from VISION as well, I think what you're quoting isfrom the Methods section of the study, specific results of the trial are tobe released at ASCO. From what I can find Novartis has just announced that thetrial "met both primary endpoints, significantly improving overall survival(OS) and radiographic progression-free survival (rPFS)".


    I don't think specific median OS in terms of monthsis yet known for us to compare the LUPIN results with.

 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.